With Midterms Looming, Journalists Consider Measles, Food Recalls, and Obamacare
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed fatal measles cases on CBS…
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed fatal measles cases on CBS News 24/7’s Mornings on Aug. 26. Gounder fact-checked Centers for Medicare & Medicaid Services Administrator Mehmet Oz’s comments about vaccines and drug prices on CBS News 24/7’s The Daily Report on Aug. 24. She also discussed food recalls this summer…
More than a dozen health systems are warning patients of a phishing campaign impersonating Epic’s MyChart portal with fake Medicare rewards and faux login pages. Experts say the scam exposes a deeper problem: patients can’t be expected to spot increasingly polished fakes, so the responsibility falls on providers to communicate in ways that build trust….
This publication describes KFF’s survey methodology and data collection standards, including how the polling team reaches survey respondents, works to be representative, and partners with other news organizations on its polling projects.
Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory disorder dermatomyositis. Licensed from Pfizer, this once-daily pill designed to block JAK1 and TYK2 proteins is also in clinical development for three additional rare immunological disorders, each with blockbuster potential. The post FDA Nod for Inflammation Drug Notches…
Partner health systems say commercially available oncology decision tool supports precise, evidence-based, and standardized care delivery at scale
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
Company adding care management technology to solution involving occupational therapists and home services for dual-eligible populations